申请人:Merrell Pharmaceuticals Inc.
公开号:US05500429A1
公开(公告)日:1996-03-19
This invention relates to 1-aryl-3-pyridinyl-2-propene-1-ones, the use of these compounds as calcium uptake inhibitors in leukocytes and thrombocytes, and pharmaceutical compositions containing these compounds as active ingredients, and the process of their preparation.
这项发明涉及1-芳基-3-吡啶基-2-丙烯-1-酮,以及这些化合物在白细胞和血小板中作为钙摄取抑制剂的用途,以及含有这些化合物作为活性成分的药物组合物,以及它们的制备过程。